Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 10, 2009, Pages 3970-3975

  Talasaz, Amirali H ^a,c   Powell, Ashley A ^b   Huber, David E ^c   Berbee, James G ^c   Roh, Kyung Ho ^c   Yu, Wong ^c   Xiao, Wenzhong ^c   Davis, Mark M ^c   Pease, R Fabian ^a   Mindrinos, Michael N ^c   Jeffrey, Stefanie S ^b   Davis, Ronald W ^c  

^a Stanford University   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Circulating tumor cells; Enrichment of rare cells; Magnetic separation

Indexed keywords

MOLECULAR MARKER;

ADULT; ARTICLE; BLOOD CELL; BREAST CANCER; CELL ISOLATION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; ENRICHMENT CULTURE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; MAGNETISM; METASTASIS; PRIORITY JOURNAL; TARGET CELL;

BLOOD CELLS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SEPARATION; COMPUTER SIMULATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HLA-A2 ANTIGEN; HUMANS; MAGNETICS; MODELS, IMMUNOLOGICAL;

EID: 62649158232     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0813188106     Document Type: Article

References (26)

1. Cristofanilli M, et al. (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781-791.
2. Hayes DF, et al. (2006) Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 12:4218-4224.
3. Budd GT, et al. (2006) Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer. Clin Cancer Res 12:6403-6409.
4. Moreno JG, et al. (2005) Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology 65:713-718.
5. Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev 8:329-340.
6. Cohen SJ, et al. (2008) Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26:3213-3221.
7. Nagrath S, et al. (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450:1235-1239.
8. Bianchi DW, Flint AF, Pizzimenti MF, Knoll JH, Latt SA (1990) Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci USA 87:3279-3283.
9. Herzenberg LA, Bianchi DW, Schroder J, Cann HM, Iverson GM (1979) Fetal cells in the blood of pregnant women: Detection and enrichment by fluorescence-activated cell sorting. Proc Natl Acad Sci USA 76:1453-1455.
10. Cheung MC, Goldberg JD, Kan YW (1996) Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet 14:264-268.
11. Moon JJ, et al. (2007) Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27:203-213.
12. Smirnov DA, et al. (2005) Global gene expression profiling of circulating tumor cells. Cancer Res 65:4993-4997.
13. Calvano SE, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437:1032-1037.
14. Berthold F (1981) Isolation of human monocytes by Ficoll density gradient centrifugation. Blut 43:367-371.
15. Kahn HJ, et al. (2004) Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: Correlation with disease stage. Breast Cancer Res Treat 86:237-247.
16. Vona G, et al. (2000) Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 156:57-63.
17. Allard WJ, et al. (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10:6897-6904.
18. Racila E, et al. (1998) Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 95:4589-4594.
19. Martin VM, et al. (1998) Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol 26:252-264.
20. Zieglschmid V, Hollmann C, Bocher O (2005) Detection of disseminated tumor cells in peripheral blood. Crit Rev Clin Lab Sci 42:155-196.
21. Cheng X, et al. (2007) A microfluidic device for practical label-free CD4(+) T cell counting of HIV-infected subjects. Lab Chip 7:170-178.
22. Momburg F, Moldenhauer G, Hammerling GJ, Moller P (1987) Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 47:2883-2891.
23. Balzar M, Winter MJ, de Boer CJ, Litvinov SV (1999) The biology of the 17-1A antigen (Ep-CAM). J Mol Med 77:699-712.
24. Rao CG, et al. (2005) Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol 27:49-57.
25. Cristofanilli M, et al. (2007) Circulating tumor cells in metastatic breast cancer: Biologic staging beyond tumor burden. Clin Breast Cancer 7:471-479.
26. Irizarry RA, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.